Proactive Investors - Run By Investors For Investors

LeanLife hits new milestone, ships first Omega-3 product samples

The Vancouver-based company developed a patented process to isolate Omega-3 fatty acids from flax seeds that can be used as food additives or nutraceuticals
omega-3
LeanLife shipped samples of its Omega-3 products to a potential consumer base in Europe

LeanLife Health Inc (CSE:LLP) has shipped its first Omega-3 product samples to potential customers in Europe, the company announced Thursday.

Shares jumped around 33% on Thursday morning to reach C$0.06 in Canada.

The Vancouver-based company develops proprietary plant-based food products that can be used as food additives or nutraceuticals. It has a patented process to isolate Omega-3 fatty acids from flax seeds.

LeanLife’s proprietary Omega-3 product was shipped to Europe, where it will be distributed to a consumer base of some of the continent’s largest producers of bread, pasta, cheese, yogurt and butter.

READ: LeanLife testing exceeds expectations, gears up for commercialization of Omega-3 fatty acids

Recently, a trial application using the Omega-3 product as a substitute for vegetable oil showed negligible difference in taste and quality, LeanLife said in a statement.

The testing resulted in the production of samples which will now be evaluated by a third-party accredited lab.

According to the extract manufacturer, the company is ready to begin large-scale production and fulfill multiple orders following the validation of samples by buyers.

CEO Stan Lis said that LeanLife is “very excited” to be back in production. “Now that LeanLife is capable of producing in large volumes, the shipping of samples to potential customers that have been waiting for our product brings the company to the verge of revenue generation in this multi-billion dollar market,” he said in a statement.

“Our salesforce in Europe has been eagerly awaiting the opportunity to revisit potential customers. As the awareness of the importance of healthy eating continues to expand, LeanLife intends to meet the growing consumer demand for plant-based essential food ingredients.”

The global Omega-3 market reached US$33 billion in 2016 and is expected to reach nearly US$57 billion by 2025, according to data provided by LeanLife.

--Updates with share price--

Contact Angela at [email protected]

Follow her on Twitter @AHarmantas

View full LLP profile View Profile

LeanLife Health Timeline

Newswire
February 07 2019

Related Articles

lab worker
Mon
Here we take a closer look at Scancell, which is at the vanguard of immuno-oncology
test tubes
April 16 2019
Summit Therapeutics' potential breakthrough targets C.difficile
seeds in a bowl
March 07 2019
The Vancouver company is developing Omega-3 products as oil, powder or emulsion to be used as food additives

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use